Equine Ins antibody and antigen (recombinant protein)

Diagnostic anti-Equine Ins antibodies pairs and antigen for animal health (animal Equine/Horse Diabetes mellitus) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-EQU-Ins-Ag01 Recombinant Equine Ins protein 3090
GMP-EQU-Ins-Ab01 Anti-Equine Ins mouse monoclonal antibody (mAb) 1953
GMP-EQU-Ins-Ab02 Anti-Equine Ins mouse monoclonal antibody (mAb) 1953
GMP-EQU-Ins-Ab03 Anti-Equine Ins human monoclonal antibody (mAb) 1953
GMP-EQU-Ins-Ab04 Anti-Equine Ins human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-EQU-Ins-Ag01
Product Name Recombinant Equine Ins protein
Target/Biomarker Equine Insulin (Ins)
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Equine Insulin antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Ins level test of animal Equine/Horse with Diabetes mellitus.
Tag His
Products description Recombinant Equine Ins protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-EQU-Ins-Ab01, GMP-EQU-Ins-Ab02
Product Name Anti-Equine Ins mouse monoclonal antibody (mAb)
Target/Biomarker Equine Insulin (Ins)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Equine Insulin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Ins antibodies in Ins level test of animal Equine/Horse with Diabetes mellitus.
Tag mFc
Products description Anti-Equine Ins mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Ins antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-EQU-Ins-Ab03, GMP-EQU-Ins-Ab04
Product Name Anti-Equine Ins human monoclonal antibody (mAb)
Target/Biomarker Equine Insulin (Ins)
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Recombinant Equine Insulin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Ins antibodies in Ins level test of animal Equine/Horse with Diabetes mellitus.
Tag hFc
Products description Anti-Equine Ins human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Ins antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Equine Insulin, an intricate peptide hormone comprising 51 amino acids, reigns supreme as a cornerstone of glucose regulation in horses. Produced and secreted by the beta cells nestled within the equine pancreas, it orchestrates a symphony of metabolic processes that dictate how horses utilize glucose for energy and storage. At its core, Equine Insulin serves as the conductor for cellular glucose uptake. Upon its release into circulation, it seeks out insulin receptors on the surfaces of target cells, notably those found in skeletal muscle and adipose tissue. This binding event sets in motion a finely tuned series of intracellular signaling pathways, culminating in the translocation of glucose transporters (GLUT4) to the cell membrane. These transporters act as the molecular gatekeepers that permit glucose entry into the cell, where it can be either converted into energy through glycolysis or stored as glycogen for future energy demands. The secretion of Equine Insulin is intricately linked to blood glucose levels. After a horse's meal, when glucose levels surge, beta cells respond by releasing insulin, effectively facilitating glucose uptake into cells and leading to a decline in blood glucose levels, restoring metabolic equilibrium. Conversely, during fasting or times of heightened energy demand, Equine Insulin secretion diminishes, allowing stored glucose to be mobilized and released into circulation to maintain vital glucose homeostasis.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment